{
    "Trade/Device Name(s)": [
        "StatStrip Xpress 2 Glucose Hospital Meter System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K152986",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150461",
        "K070960"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PZI",
        "CGA"
    ],
    "Summary Letter Date": "March 1, 2019",
    "Summary Letter Received Date": "December 28, 2015",
    "Submission Date": "December 22, 2015",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary finger stick whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonate arterial whole blood",
        "Neonate heel stick"
    ],
    "Specimen Container(s)": [
        "Single-use, auto-disabling lancing device"
    ],
    "Instrument(s)/Platform(s)": [
        "StatStrip Xpress 2 Glucose Hospital Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase electrochemical biosensor"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Test strip",
        "Control solution",
        "Linearity solution"
    ],
    "Document Summary": "FDA 510(k) summary for StatStrip Xpress 2 Glucose Hospital Meter System with quantitative glucose determination in various whole blood specimen types for point-of-care hospital use",
    "Indications for Use Summary": "Quantitative determination of glucose in capillary finger stick, venous, arterial, neonatal arterial, and neonatal heel stick whole blood specimens at point-of-care in hospital/professional settings; not for diabetes diagnosis but for dysglycemia monitoring",
    "fda_folder": "Clinical Chemistry"
}